Clinical Utility of NGS in Lymphoid Malignancies including Minimal Residual Disease (MRD) testing← ALL VIDEOSClinical Utility of NGS in Lymphoid Malignancies including Minimal Residual Disease (MRD) testingNovember 16th, 2020FEATURED PRESENTERS Yury Monczak, Ph.D / Ryan J. Schmidt, MD, PhD marketing2021-02-23T01:19:53+00:00
